A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world
about
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis.The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease.Synergy between 5-HT4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle.
P2860
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A longitudinal, retrospective ...... ase patients in the real world
@ast
A longitudinal, retrospective ...... ase patients in the real world
@en
type
label
A longitudinal, retrospective ...... ase patients in the real world
@ast
A longitudinal, retrospective ...... ase patients in the real world
@en
prefLabel
A longitudinal, retrospective ...... ase patients in the real world
@ast
A longitudinal, retrospective ...... ase patients in the real world
@en
P2093
P2860
P356
P1476
A longitudinal, retrospective ...... ase patients in the real world
@en
P2093
Andrew F Shorr
Shawn X Sun
Shelby Corman
Xingyue Huang
P2860
P304
P356
10.2147/COPD.S80106
P407
P577
2015-10-07T00:00:00Z